Search Constraints
Search Results
Select an image to start the slideshow
A Statement
1 of 66
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
2 of 66
Appendix C: Program of the International Conference on Recombinant DNA Molecules
3 of 66
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
4 of 66
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
5 of 66
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
6 of 66
Appendix F: Cloned Eukaryotic DNA
7 of 66
Appendix F: Cloned Eukaryotic DNA
8 of 66
Appendix H: Provisional Statement of the Conference Proceedings
9 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
10 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
11 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
12 of 66
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
13 of 66
David Baltimore speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
14 of 66
David Hogness speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
15 of 66
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
16 of 66
Letter from Carolyn E. Kemp to Maxine Singer
17 of 66
Letter from Charles Warren and Barry Keene to Maxine Singer
18 of 66
Letter from David Baltimore to Fred C. Ikle
19 of 66
Letter from David S. Hogness to DeWitt Stetten, Jr
20 of 66
Letter from Joshua Lederberg to U.S. Senators Alan Cranston and Samuel Ichiye Hayakawa
21 of 66
Letter from London Ganning to Maxine Singer
22 of 66
Letter from Maxine Singer to Carolyn E. Kemp
23 of 66
Letter from Maxine Singer to Charles Warren
24 of 66
Letter from Maxine Singer to Donald S. Fredrickson
25 of 66
Letter from Maxine Singer to London Ganning
26 of 66
Letter from Maxine Singer to Lorill Brown-Rezanka
27 of 66
Letter from Maxine Singer to Milton P. Gordon
28 of 66
Letter from Maxine Singer to Robert L. Sinsheimer
29 of 66
Letter from Maxine Singer to U.S. Representative Richard Ottinger
30 of 66
Letter from Maxine Singer to Wallace P. Rowe
31 of 66
Letter from Maxine Singer to Willard Gaylin
32 of 66
Letter from Maxine Singer to William J. Gartland
33 of 66
Letter from Paul Berg to Robert L. Sinsheimer
34 of 66
Letter from Paul Berg to U.S. Senator Harrison Schmitt
35 of 66
Letter from Roy Curtiss III to Donald S. Fredrickson
36 of 66
Letter from Roy Curtiss III to Donald S. Fredrickson
37 of 66
Letter from Roy Curtiss III to Maxine Singer
38 of 66
Letter from Stanley N. Cohen to Maxine Singer
39 of 66
Letter from U.S. Representative Paul G. Rogers to Maxine Singer
40 of 66
Letter from Wallace P. Rowe to Maxine Singer
41 of 66
Maxine Singer speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
42 of 66
Maxine Singer, Norton Zinder, Sydney Brenner, and Paul Berg at the 1975 Asilomar Conference
43 of 66
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
44 of 66
Memorandum from Maxine Singer to Donald S. Fredrickson
45 of 66
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
46 of 66
Memorandum from Michael Adler [summarizing the first day of hearings of the Thornton House Subcommittee on Science, Research, and Technology]
47 of 66
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
48 of 66
Minutes of the Eleventh Meeting of the Executive Recombinant DNA Committee
49 of 66
Open Letter to the Asilomar Conference on Hazards of Recombinant DNA
50 of 66
Ordinance No. 5010: Regulating the Use of Hazardous Biological Research in the City of Berkeley
51 of 66
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
52 of 66
Paul Berg speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
53 of 66
Potential Biohazards of Recombinant DNA Molecules [Letter to the Editor of Science]
54 of 66
Protestors and their banner at the March 1977 National Academy of Sciences Forum on Recombinant DNA
55 of 66
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
56 of 66
Robert Sinsheimer speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
57 of 66
Roy Curtiss III speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
58 of 66
Roy Hudson listening in at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
59 of 66
Speaker from the audience at the March 1977 National Academy of Sciences Forum on Recombinant DNA
60 of 66
Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
61 of 66
Susan Wright speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
62 of 66
Testimony by David Baltimore for the Committee on Science and Technology
63 of 66
Testimony of Maxine Singer before the California State Legislature
64 of 66
The Scientific Committee on Genetic Experimentation (COGENE)
65 of 66
Wallace Rowe speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
66 of 66